Gunduz, S. Et Al. 2013. YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).

Gunduz, S., ÖZGÜR, Ö., Bozcuk, H., COŞKUN, H. Ş., Ozdogan, M., Erkilic, M., ... SİNDEL, H. T.(2013). YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands

Gunduz, ŞEYDA Et Al. "YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013

Gunduz, ŞEYDA Et Al. "YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013

Gunduz, S. Et Al. (2013) . "YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={ŞEYDA GÜNDÜZ Et Al. }, title={YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}